From: Impact of minimally invasive mitral valve surgery on sexual dysfunction in male patients
Item | MVS group | MIMVS group | P |
---|---|---|---|
Sexual dysfunction | 30 | 15 | 0.03 |
Age (years) | 45.25 ± 9.05 | 45.93 ± 9.90 | 0.71 |
BMI (kg/m2) | 22.53 ± 1.75 | 22.74 ± 1.48 | 0.50 |
Marriage | 47 | 40 | 0.86 |
Smoke | 22 | 15 | 0.46 |
Hypertension | 8 | 10 | 0.35 |
Diabetes | 5 | 4 | 1 |
β-blocker | 50 | 39 | 0.47 |
Pre-operative NYHA (median) | II | II | Â |
Pre-operative LVEF (%) | 57.05 ± 5.86 | 58.30 ± 6.85 | 0.30 |
Surgery strategy | Â | Â | 0.09 |
Mitral valve repair | 35 | 21 | Â |
Mitral valve replacement | 26 | 30 | Â |
Tricuspid valve plasty | 20 | 19 | 0.48 |
Post-operative LVEF (%) | 56.21 ± 5.40 | 55.20 ± 5.01 | 0.31 |
Post-operative NYHA (median) | I | I | Â |
Postoperative hospital stays (days) | 5.88 ± 0.94 | 4.87 ± 0.75 | P < 0.001 |